• Kura Oncology Chief Commercial Officer Brian T. Powl sold 339 shares of common stock on May 19, 2026 at USD 9.21.
• Powl held 183,614 shares following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-232547), on May 20, 2026, and is solely responsible for the information contained therein.